IL-9作为一种具有最佳JAK/STAT信号传递的自然正交细胞因子,用于工程T细胞治疗
Hua Jiang1,2,3, Sam Limsuwannarot1,3, Kayla R Kulhanek1,4,5,3
1Department of Radiation Oncology, Stanford University School of Medicine. Stanford, CA, 94305, USA.
bioRxiv : the preprint server for biology
|January 27, 2025
概括
使用天然的互乐金-9受体 (IL-9R) 改造的T细胞显示出增强的抗瘤活性和组织透. 这种天然的细胞因子-受体对为T细胞免疫疗法提供了最佳的信号配置.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 癌症治疗 癌症治疗
背景情况:
- 介素-9受体 (IL-9R) 的自然表达有限,这表明有针对性T细胞免疫疗法的潜力.
- 在没有显著免疫调节的小鼠中,高剂量的干白素-9 (IL-9) 可以耐受,这表明了有利的安全性.
研究的目的:
- 研究自然IL-9/IL-9R系统在工程T细胞治疗中的潜力.
- 为了比较与天然IL-9R工程T细胞与合成正交IL-9受体 (o9R) 的疗效.
主要方法:
- 工程T细胞与自然IL-9R,并将其功能与o9R工程T细胞进行比较.
- 分析JAK/STAT信号通路,包括STAT1,STAT3,STAT5和STAT4激活.
- 利用结构引导突变调节IL-9R信号,并评估其对T细胞状态的影响.
主要成果:
- 与o9R相比,与天然IL-9R进行工程的T细胞表现出优异的组织透,干性和抗瘤活性.
- IL-9R信号激活了一个强大的JAK/STAT通路,意外地涉及STAT4,以及STAT1,STAT3和STAT5.
- 特定的IL-9R突变显示STAT1是控制T细胞增殖和分化的平衡的关键调节者.
结论:
- 自然的IL-9/IL-9R细胞因子-受体对具有适合T细胞工程的近直角性质.
- IL-9/IL-9R系统提供了最佳的JAK/STAT信号配置,以提高T细胞治疗的疗效.
更多相关视频
07:20Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
Published on: January 14, 2011
14.7K
06:16Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
Published on: December 7, 2019
12.6K
相关概念视频
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
T Cell Types and Functions
942
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
942
Tumor Immunotherapy
466
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
466
